PlainRecalls
FDA Drug Low Class III Ongoing

Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-125-91

Reported: November 5, 2025 Initiated: October 10, 2025 #D-0139-2026

Product Description

Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-125-91

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

Details

Recalling Firm
Endo USA, Inc.
Units Affected
6,655 cartons
Distribution
Nationwide within the United States
Location
Malvern, PA

Frequently Asked Questions

What product was recalled?
Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-125-91. Recalled by Endo USA, Inc.. Units affected: 6,655 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 5, 2025. Severity: Low. Recall number: D-0139-2026.